{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"BioBreakthroughs","title":"#16 - Javier Szwarcberg, CEO of Spruce Biosciences","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/e6e668d3\"></iframe>","width":"100%","height":180,"duration":915,"description":"Join us on the latest episode! Our Guest: Javier Swarcberg, CEO of Spruce Biosciences\nWhat you'll get out of this episode:\nDive deep into the world of Congenital Adrenal Hyperplasia (CAH) treatments and drug development.\nUnderstand the challenges and rewards of addressing rare diseases, especially in pediatrics.\nJavier Szwarcberg discusses Spruce's innovative Tildesophon and its potential impact on the CAH therapeutic landscape.\nDiscover the upcoming clinical updates from Spruce Biosciences and the promising future outlook for CH treatments.\n\nTo learn more about Spruce Biosciences: https://sprucebio.com/\nOur sponsors for this episode are:\nSage Growth Partners https://sage-growth.com/","thumbnail_url":"https://img.transistorcdn.com/roxGfgcNItysBs3fg55SsdSx4l_Pbz86Ktm2KMDYkR4/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9zaG93/LzQwNjg1LzE2ODE5/MzQxODQtYXJ0d29y/ay5qcGc.webp","thumbnail_width":300,"thumbnail_height":300}